Literature DB >> 27824047

Lung cancer: Best supportive care - a reasonable option for patients with brain metastases?

Dirk Rades1, Steven E Schild2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27824047     DOI： 10.1038/nrclinonc.2016.179

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

1.  Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.

Authors:  Katarzyna Komosinska; Lucyna Kepka; Anna Niwinska; Lucyna Pietrzak; Marek Wierzchowski; Dobromira Tyc-Szczepaniak; Agnieszka Kaczmarczyk; Krzysztof Bujko
Journal:  Acta Oncol       Date:  2010-04       Impact factor: 4.089

2.  A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone.

Authors:  Dirk Rades; Liesa Dziggel; Viorica Nagy; Barbara Segedin; Radka Lohynska; Theo Veninga; Mai T Khoa; Ngo T Trang; Steven E Schild
Journal:  Radiother Oncol       Date:  2013-07-03       Impact factor: 6.280

3.  A new survival score for patients with brain metastases from non-small cell lung cancer.

Authors:  D Rades; L Dziggel; B Segedin; I Oblak; V Nagy; A Marita; S E Schild; N T Trang; M T Khoa
Journal:  Strahlenther Onkol       Date:  2013-06-07       Impact factor: 3.621

4.  Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis.

Authors:  Dirk Rades; Annika Panzner; Liesa Dziggel; Tiina Haatanen; Radka Lohynska; Steven E Schild
Journal:  Cancer       Date:  2011-12-13       Impact factor: 6.860

5.  Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.

Authors:  Jennifer Wong; Amanda Hird; Liying Zhang; May Tsao; Emily Sinclair; Elizabeth Barnes; Cyril Danjoux; Edward Chow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-21       Impact factor: 7.038

6.  Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

Authors:  Paul W Sperduto; Samuel T Chao; Penny K Sneed; Xianghua Luo; John Suh; David Roberge; Amit Bhatt; Ashley W Jensen; Paul D Brown; Helen Shih; John Kirkpatrick; Amanda Schwer; Laurie E Gaspar; John B Fiveash; Veronica Chiang; Jonathan Knisely; Christina Maria Sperduto; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-26       Impact factor: 7.038

7.  Brain metastasis from non-small cell lung cancer (NSCLC): prognostic importance of the number of involved extracranial organs.

Authors:  L Gerdan; B Segedin; V Nagy; M T Khoa; N T Trang; S E Schild; D Rades
Journal:  Strahlenther Onkol       Date:  2013-10-09       Impact factor: 3.621

8.  Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.

Authors:  Dirk Rades; Steven E Schild; Radka Lohynska; Theo Veninga; Lukas J A Stalpers; Juergen Dunst
Journal:  Cancer       Date:  2007-09-01       Impact factor: 6.860

9.  Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.

Authors:  Paula Mulvenna; Matthew Nankivell; Rachael Barton; Corinne Faivre-Finn; Paula Wilson; Elaine McColl; Barbara Moore; Iona Brisbane; David Ardron; Tanya Holt; Sally Morgan; Caroline Lee; Kathryn Waite; Neil Bayman; Cheryl Pugh; Benjamin Sydes; Richard Stephens; Mahesh K Parmar; Ruth E Langley
Journal:  Lancet       Date:  2016-09-04       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.